Purgatory said...
Its been a well known and document fact, that African-American men have a higher percentage of prostate cancer per population, and that fact has nothing to do with the American Cancer Society or their screwy "modified" guidelines. Couldn't imagine anyone one that studies PC that didn't know that.
I've read the ACS Guidelines. I thought it would be helpful to post some of the highlights (since news media releases often ignores the meaty details):
ACS Guidelines encourages that men in risk categories begin having dialogue about the importance of PSA testing by age 40. (50 for men of no additional risk).
The most important risk categories include African-Americans race and men with PC in non-elderly relatives (under 65).
Men should either receive this information directly from their health care providers or be referred to reliable appropriate sources. The screening decision is made best in partnership with a trusted source of regular care. For men who choose to be screened after considering the possible benefits and risks, the ACS goes on to say:
- Screening should be conducted yearly for men whose PSA level is 2.5 ng/mL or greater
- For men whose PSA is less than 2.5 ng/mL, screening intervals can be extended to every 2 years
- A PSA level of 4.0 ng/mL or greater historically has been used to recommend referal for further evaluation or biopsy, which remains a reasonable approach for men at average risk for PC
- For PSA levels between 2.5 and 4.0 ng/mL, health care providers should consider an individualized risk assessment that incorporates other risk factors for PC, particularly for high-grade cancer, that may be used to recommend a biopsy. Factors that increase the risk of PC include African-American race, family history of PC, increased age, and abnormal DRE.
hope this helps...
--------------------------------------------
added later (10:09am) as an edit:
BTW, the ACS Guidelines were created by the ACS Prostate Cancer Advisory Committee, through a consensus process which is documented & described in the document itself. These individuals or institutions were present on the committee:
University of Virginia School of Medicine, Charlottesville, VA; University of Maryland School of Medicine, Baltimore, MD; Gerald Chodak, MD, Chicago, IL; Dana-Farber Cancer Institute and Professor of Radiation Oncology, Harvard Medical School, Boston, MA; Fred Hutchinson Cancer Research Center, Seattle, WA; Cabrillo Radiation Oncology Medical Center and Coastal Radiation Oncology Medical Group, Ventura, CA; University of North Carolina School of Medicine and Member, Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Emory University School of Medicine, Atlanta, GA; Hartford Hospital, Hartford, CT; The University of Texas Health Science Center, San Antonio, TX; Thomas Jefferson University Medical College, Philadelphia, PA
Reading some of the Dr Otis Brawley-bashing that takes places, one would think that he personally wrote every word.
Reading
Post Edited (Casey59) : 6/1/2010 9:09:09 AM (GMT-6)